Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3741101
Max Phase: Preclinical
Molecular Formula: C24H19NO3
Molecular Weight: 369.42
Molecule Type: Small molecule
Associated Items:
ID: ALA3741101
Max Phase: Preclinical
Molecular Formula: C24H19NO3
Molecular Weight: 369.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)c1cccc(NC(c2ccccc2)c2ccc3ccccc3c2O)c1
Standard InChI: InChI=1S/C24H19NO3/c26-23-20-12-5-4-7-16(20)13-14-21(23)22(17-8-2-1-3-9-17)25-19-11-6-10-18(15-19)24(27)28/h1-15,22,25-26H,(H,27,28)
Standard InChI Key: TUHAYLBLXPNFBE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.42 | Molecular Weight (Monoisotopic): 369.1365 | AlogP: 5.45 | #Rotatable Bonds: 5 |
Polar Surface Area: 69.56 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.76 | CX Basic pKa: 2.03 | CX LogP: 5.30 | CX LogD: 2.69 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.44 | Np Likeness Score: -0.63 |
1. Mohammed I, Hampton SE, Ashall L, Hildebrandt ER, Kutlik RA, Manandhar SP, Floyd BJ, Smith HE, Dozier JK, Distefano MD, Schmidt WK, Dore TM.. (2016) 8-Hydroxyquinoline-based inhibitors of the Rce1 protease disrupt Ras membrane localization in human cells., 24 (2): [PMID:26706114] [10.1016/j.bmc.2015.11.043] |
Source(1):